Combination of Palbociclib and Erlotinib Exhibits Synergistic Antitumor Effect in Colorectal Cancer Patient-Derived Xenograft (PDX) Models

Xiaohui Zhou(Nanjing Medical University), Fan Lin(University of Chinese Academy of Sciences), Chao Chen(Children's Hospital of Fudan University), Zhen Chen(Qingdao University), Xiaorong Liu(Hunan University of Traditional Chinese Medicine), Yang Liu(Jiangsu Cancer Hospital), Tingting Zhou(Nanjing Medical University), Xin Shi(Zhongda Hospital Southeast University), Yeqing Gong(Nanjing Medical University), Yunfen Hua(Zhejiang University of Science and Technology), Jiaqi Mao(Wenzhou University)
Research Square
January 7, 2021
Cited by 2


Related Papers